1,101 results on '"Hey, John"'
Search Results
2. Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using Quantitative Systems Pharmacology Model
3. The determinants of decision time in an ambiguous context
4. Dynamic inconsistency under ambiguity: An experiment
5. The Acceptability of Accountability
6. Why do consumers not switch? An experimental investigation of a search and switch model
7. The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
8. The determinants of decision time in an ambiguous context
9. Decisions under risk: Dispersion and skewness
10. Reduction of Hippocampal Atrophy and Lateral Ventricle Enlargement Correlates with Clinical Benefit in APOE4 Carriers with Early AD: 1‐Year Results from a Phase 2 Biomarker Study with Oral Anti‐Amyloid Oligomer Inhibitor ALZ‐801
11. Prevalence of Cerebral Microhemorrhages and Cortical Superficial Siderosis in APOE4/4 Homozygotes with Early Alzheimer’s disease: Baseline Findings from Phase 3 Trial of Oral ALZ‐801 in APOE4/4 Homozygotes (APOLLOE4)
12. Testing for the emergence of spontaneous order
13. Isomers and energy landscapes of micro-hydrated sulfite and chlorate clusters
14. Editorial: Foundations of Utility and Risk Conference (FUR 2018)
15. Context matters
16. Do Markets Drive out Lemmings: Or Vice Versa?
17. The Effect of Unemployment on Consumption: An Experimental Analysis
18. Elicitation of preferences under ambiguity
19. Prevalence of Amyloid-Related Imaging Abnormalities in APOE4/4 Homozygotes with Early Alzheimer’s Disease: Baseline Findings from Ongoing Clinical Trials of Oral Anti-Amyloid Agent ALZ-801 (Valiltramiprosate) (P5-6.003)
20. Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD (S26.007)
21. Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
22. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain
23. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
24. Assessing multiple prior models of behaviour under ambiguity
25. EXPERIMENTAL EVIDENCE ON ENGLISH AUCTIONS: ORAL OUTCRY VERSUS CLOCK
26. Strategies in dynamic decision making – An experimental investigation of the rationality of decision behaviour
27. The descriptive and predictive adequacy of theories of decision making under uncertainty/ambiguity
28. Discriminating between Preference Functionals: A Preliminary Monte Carlo Study
29. Naive, resolute or sophisticated? A study of dynamic decision making
30. Are Preference Reversals Errors? An Experimental Investigation
31. Do Markets Drive Out Lemmings—or Vice Versa?
32. Which Error Story is Best?
33. Experimental investigations of errors in decision making under risk
34. What price compromise?
35. Dynamic decision making: what do people do?
36. Does Repetition Improve Consistency?
37. Does money impede convergence?
38. COMPARING THEORIES: WHAT ARE WE LOOKING FOR?
39. How far ahead do people plan?
40. Why We Should Not Be Silent About Noise
41. Mixture models of choice under risk
42. When and how to satisfice: an experimental investigation
43. INVESTIGATING GENERALIZATIONS OF EXPECTED UTILITY THEORY USING EXPERIMENTAL DATA
44. The explanatory and predictive power of non two-stage-probability theories of decision making under ambiguity
45. Effects of Oral ALZ‐801, an Amyloid Oligomer Inhibitor, on Plasma Biomarkers in APOE4 Carriers with Early Alzheimer’s Disease: Results of Six‐month Interim Analysis from a Phase 2 Biomarker Study
46. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data
47. When and how to satisfice: an experimental investigation
48. Georges-Louis Leclerc de Buffon’s ‘Essays on Moral Arithmetic’
49. The explanatory and predictive power of non two-stage-probability theories of decision making under ambiguity
50. Does money impede convergence?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.